-+ 0.00%
-+ 0.00%
-+ 0.00%

Nexalin closes acquisition of PONM digital health platform for USD 1.3 million

PUBT·05/19/2026 12:31:35
Listen to the news
Nexalin closes acquisition of PONM digital health platform for USD 1.3 million
  • Nexalin closed the acquisition of PONM from GreenLight Ventures, bringing in-house the digital health platform used for the HALO Clarity program and the Nexalin NeuroCare virtual clinic.
  • Consideration totals $1.3 million, paid in tranches of Nexalin common stock priced to the company’s market performance.
  • The deal includes an exclusive license to software features supporting AI-enabled remote patient monitoring, treatment compliance tracking, EHR functions, and virtual-clinic management.
  • The platform is already deployed at UC San Diego and is being prepared to support a planned 160-participant FDA pivotal trial of HALO Clarity for moderate-to-severe insomnia, with enrollment expected to start in Q2 2026.
  • GreenLight becomes an equity holder in Nexalin and enters a strategic partnership to provide ongoing product, engineering, cybersecurity, regulatory, and commercialization support.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexalin Technology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605190830PRIMZONEFULLFEED9722642) on May 19, 2026, and is solely responsible for the information contained therein.